[1]
|
Wang, Y., Hu, H., Wang, Q., Li, Z., Zhu, Y., Zhang, W., et al. (2017) The Level and Clinical Significance of 5-Hydroxymethylcytosine in Oral Squamous Cell Carcinoma: An Immunohistochemical Study in 95 Patients. Pathology—Research and Practice, 213, 969-974. https://doi.org/10.1016/j.prp.2017.04.016
|
[2]
|
Panarese, I., Aquino, G., Ronchi, A., Longo, F., Montella, M., Cozzolino, I., et al. (2019) Oral and Oropharyngeal Squamous Cell Carcinoma: Prognostic and Predictive Parameters in the Etiopathogenetic Route. Expert Review of Anticancer Therapy, 19, 105-119. https://doi.org/10.1080/14737140.2019.1561288
|
[3]
|
Takeuchi, O. and Akira, S. (2010) Pattern Recognition Receptors and Inflammation. Cell, 140, 805-820. https://doi.org/10.1016/j.cell.2010.01.022
|
[4]
|
Kim, Y.K., Shin, J. and Nahm, M.H. (2016) Nod-Like Receptors in Infection, Immunity, and Diseases. Yonsei Medical Journal, 57, 5-14. https://doi.org/10.3349/ymj.2016.57.1.5
|
[5]
|
Liston, A. and Masters, S.L. (2017) Homeostasis-Altering Molecular Processes as Mechanisms of Inflammasome Activation. Nature Reviews Immunology, 17, 208-214. https://doi.org/10.1038/nri.2016.151
|
[6]
|
Mangan, M.S.J., Olhava, E.J., Roush, W.R., Seidel, H.M., Glick, G.D. and Latz, E. (2018) Targeting the NLRP3 Inflammasome in Inflammatory Diseases. Nature Reviews Drug Discovery, 17, 588-606. https://doi.org/10.1038/nrd.2018.97
|
[7]
|
Kelley, N., Jeltema, D., Duan, Y. and He, Y. (2019) The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. International Journal of Molecular Sciences, 20, Article 3328. https://doi.org/10.3390/ijms20133328
|
[8]
|
Vandanmagsar, B., Youm, Y., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L., et al. (2011) The NLRP3 Inflammasome Instigates Obesity-Induced Inflammation and Insulin Resistance. Nature Medicine, 17, 179-188. https://doi.org/10.1038/nm.2279
|
[9]
|
He, Y., Hara, H. and Núñez, G. (2016) Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends in Biochemical Sciences, 41, 1012-1021. https://doi.org/10.1016/j.tibs.2016.09.002
|
[10]
|
Xue, Y., Enosi Tuipulotu, D., Tan, W.H., Kay, C. and Man, S.M. (2019) Emerging Activators and Regulators of Inflammasomes and Pyroptosis. Trends in Immunology, 40, 1035-1052. https://doi.org/10.1016/j.it.2019.09.005
|
[11]
|
Rathinam, V.A.K. and Fitzgerald, K.A. (2016) Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell, 165, 792-800. https://doi.org/10.1016/j.cell.2016.03.046
|
[12]
|
De Nardo, D. and Latz, E. (2011) NLRP3 Inflammasomes Link Inflammation and Metabolic Disease. Trends in Immunology, 32, 373-379. https://doi.org/10.1016/j.it.2011.05.004
|
[13]
|
Davis, B.K., Wen, H. and Ting, J.P.-. (2011) The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases. Annual Review of Immunology, 29, 707-735. https://doi.org/10.1146/annurev-immunol-031210-101405
|
[14]
|
Martinon, F., Burns, K. and Tschopp, J. (2002) The Inflammasome. Molecular Cell, 10, 417-426. https://doi.org/10.1016/s1097-2765(02)00599-3
|
[15]
|
Doyle, S., Ozaki, E. and Campbell, M. (2015) Targeting the NLRP3 Inflammasome in Chronic Inflammatory Diseases: Current Perspectives. Journal of Inflammation Research, 8, 15-27. https://doi.org/10.2147/jir.s51250
|
[16]
|
Menu, P. and Vince, J.E. (2011) The NLRP3 Inflammasome in Health and Disease: The Good, the Bad and the Ugly. Clinical and Experimental Immunology, 166, 1-15. https://doi.org/10.1111/j.1365-2249.2011.04440.x
|
[17]
|
Mason, D.R., Beck, P.L. and Muruve, D.A. (2011) Nucleotide-Binding Oligomerization Domain-Like Receptors and Inflammasomes in the Pathogenesis of Non-Microbial Inflammation and Diseases. Journal of Innate Immunity, 4, 16-30. https://doi.org/10.1159/000334247
|
[18]
|
Gurung, P. and Kanneganti, T. (2015) Novel Roles for Caspase-8 in Il-1β and Inflammasome Regulation. The American Journal of Pathology, 185, 17-25. https://doi.org/10.1016/j.ajpath.2014.08.025
|
[19]
|
O’Connor, W., Harton, J.A., Zhu, X., Linhoff, M.W. and Ting, J.P. (2003) Cutting Edge: CIAS1/Cryopyrin/PYPAF1/NALP3/CATERPILLER1.1 Is an Inducible Inflammatory Mediator with NF-κB Suppressive Properties. The Journal of Immunology, 171, 6329-6333. https://doi.org/10.4049/jimmunol.171.12.6329
|
[20]
|
Hoffman, H.M., Mueller, J.L., Broide, D.H., Wanderer, A.A. and Kolodner, R.D. (2001) Mutation of a New Gene Encoding a Putative Pyrin-Like Protein Causes Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome. Nature Genetics, 29, 301-305. https://doi.org/10.1038/ng756
|
[21]
|
Lupfer, C. and Kanneganti, T. (2013) The Expanding Role of NLRs in Antiviral Immunity. Immunological Reviews, 255, 13-24. https://doi.org/10.1111/imr.12089
|
[22]
|
Duncan, J.A., Gao, X., Huang, M.T., O’Connor, B.P., Thomas, C.E., Willingham, S.B., et al. (2009) Neisseria gonorrhoeae Activates the Proteinase Cathepsin B to Mediate the Signaling Activities of the NLRP3 and ASC-Containing Inflammasome. The Journal of Immunology, 182, 6460-6469. https://doi.org/10.4049/jimmunol.0802696
|
[23]
|
Deretic, V. (2011) Autophagy in Immunity and Cell‐autonomous Defense against Intracellular Microbes. Immunological Reviews, 240, 92-104. https://doi.org/10.1111/j.1600-065x.2010.00995.x
|
[24]
|
Galluzzi, L. and Green, D.R. (2019) Autophagy-independent Functions of the Autophagy Machinery. Cell, 177, 1682-1699. https://doi.org/10.1016/j.cell.2019.05.026
|
[25]
|
Zaheer, A., Zaheer, S., Sahu, S.K., Knight, S., Khosravi, H., Mathur, S.N., et al. (2006) A Novel Role of Glia Maturation Factor: Induction of Granulocyte‐Macrophage Colony‐Stimulating Factor and Pro‐Inflammatory Cytokines. Journal of Neurochemistry, 101, 364-376. https://doi.org/10.1111/j.1471-4159.2006.04385.x
|
[26]
|
Deretic, V., Jiang, S. and Dupont, N. (2012) Autophagy Intersections with Conventional and Unconventional Secretion in Tissue Development, Remodeling and Inflammation. Trends in Cell Biology, 22, 397-406. https://doi.org/10.1016/j.tcb.2012.04.008
|
[27]
|
Zhou, H., Feng, L., Xu, F., Sun, Y., Ma, Y., Zhang, X., et al. (2017) Berberine Inhibits Palmitate-Induced NLRP3 Inflammasome Activation by Triggering Autophagy in Macrophages: A New Mechanism Linking Berberine to Insulin Resistance Improvement. Biomedicine & Pharmacotherapy, 89, 864-874. https://doi.org/10.1016/j.biopha.2017.03.003
|
[28]
|
Liu, P., Huang, G., Wei, T., Gao, J., Huang, C., Sun, M., et al. (2018) Sirtuin 3-Induced Macrophage Autophagy in Regulating NLRP3 Inflammasome Activation. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1864, 764-777. https://doi.org/10.1016/j.bbadis.2017.12.027
|
[29]
|
Spalinger, M.R., Kasper, S., Gottier, C., Lang, S., Atrott, K., Vavricka, S.R., et al. (2016) NLRP3 Tyrosine Phosphorylation Is Controlled by Protein Tyrosine Phosphatase PTPN22. Journal of Clinical Investigation, 126, 1783-1800. https://doi.org/10.1172/jci83669
|
[30]
|
Nurmi, K., Kareinen, I., Virkanen, J., Rajamäki, K., Kouri, V., Vaali, K., et al. (2016) Hemin and Cobalt Protoporphyrin Inhibit NLRP3 Inflammasome Activation by Enhancing Autophagy: A Novel Mechanism of Inflammasome Regulation. Journal of Innate Immunity, 9, 65-82. https://doi.org/10.1159/000448894
|
[31]
|
Spalinger, M.R., Lang, S., Gottier, C., Dai, X., Rawlings, D.J., Chan, A.C., et al. (2017) PTPN22 Regulates NLRP3-Mediated IL1B Secretion in an Autophagy-Dependent Manner. Autophagy, 13, 1590-1601. https://doi.org/10.1080/15548627.2017.1341453
|
[32]
|
Yang, S., Xia, C., Li, S., Du, L., Zhang, L. and Zhou, R. (2014) Defective Mitophagy Driven by Dysregulation of Rheb and KIF5B Contributes to Mitochondrial Reactive Oxygen Species (ROS)-Induced Nod-Like Receptor 3 (NLRP3) Dependent Proinflammatory Response and Aggravates Lipotoxicity. Redox Biology, 3, 63-71. https://doi.org/10.1016/j.redox.2014.04.001
|
[33]
|
Wu, J., Li, X., Zhu, G., Zhang, Y., He, M. and Zhang, J. (2016) The Role of Resveratrol-Induced Mitophagy/Autophagy in Peritoneal Mesothelial Cells Inflammatory Injury via NLRP3 Inflammasome Activation Triggered by Mitochondrial ROS. Experimental Cell Research, 341, 42-53. https://doi.org/10.1016/j.yexcr.2016.01.014
|
[34]
|
Wang, H., Peng, W., Ouyang, X., Li, W. and Dai, Y. (2012) Circulating microRNAs as Candidate Biomarkers in Patients with Systemic Lupus Erythematosus. Translational Research, 160, 198-206. https://doi.org/10.1016/j.trsl.2012.04.002
|
[35]
|
Bachar-Wikstrom, E., Wikstrom, J.D., Kaiser, N., Cerasi, E. and Leibowitz, G. (2013) Improvement of ER Stress-Induced Diabetes by Stimulating Autophagy. Autophagy, 9, 626-628. https://doi.org/10.4161/auto.23642
|
[36]
|
Shi, H., Zhang, Z., Wang, X., Li, R., Hou, W., Bi, W., et al. (2015) Inhibition of Autophagy Induces Il-1β Release from ARPE-19 Cells via ROS Mediated NLRP3 Inflammasome Activation under High Glucose Stress. Biochemical and Biophysical Research Communications, 463, 1071-1076. https://doi.org/10.1016/j.bbrc.2015.06.060
|
[37]
|
Apte, R.N., Krelin, Y., Song, X., Dotan, S., Recih, E., Elkabets, M., et al. (2006) Effects of Micro-Environment-and Malignant Cell-Derived Interleukin-1 in Carcinogenesis, Tumour Invasiveness and Tumour-Host Interactions. European Journal of Cancer, 42, 751-759. https://doi.org/10.1016/j.ejca.2006.01.010
|
[38]
|
Apte, R.N. and Voronov, E. (2008) Is Interleukin‐1 a Good or Bad ‘Guy’ in Tumor Immunobiology and Immunotherapy? Immunological Reviews, 222, 222-241. https://doi.org/10.1111/j.1600-065x.2008.00615.x
|
[39]
|
叶玉妹, 陈隆望, 张万里, 等. NLRP3炎症小体抑制剂MCC950通过抑制Th1/Th17和促进Tregs改善脓毒症小鼠器官损伤[J]. 温州医科大学学报, 2024, 54(3): 190-198.
|
[40]
|
Shinriki, S., Jono, H., Ueda, M., Ota, K., Ota, T., Sueyoshi, T., et al. (2011) Interleukin‐6 Signalling Regulates Vascular Endothelial Growth Factor‐C Synthesis and Lymphangiogenesis in Human Oral Squamous Cell Carcinoma. The Journal of Pathology, 225, 142-150. https://doi.org/10.1002/path.2935
|
[41]
|
Shintani, S., Ishikawa, T., Nonaka, T., Li, C., Nakashiro, K., Wong, D.T.W., et al. (2004) Growth-Regulated Oncogene-1 Expression Is Associated with Angiogenesis and Lymph Node Metastasis in Human Oral Cancer. Oncology, 66, 316-322. https://doi.org/10.1159/000078333
|
[42]
|
史国军, 王永生, 何国浓, 等. 冬凌草甲素逆转BEL-7402/5-FU化疗耐药作用的体内研究[J]. 浙江中西医结合杂志, 2023, 33(10): 888-892, 908.
|
[43]
|
Scuderi, S.A., Casili, G., Basilotta, R., Lanza, M., Filippone, A., Raciti, G., et al. (2021) NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression. International Journal of Molecular Sciences, 22, Article 11108. https://doi.org/10.3390/ijms222011108
|
[44]
|
Zi, M., Chen, X.Y., Yang, C., Su, X.D., Lv, S.X. and Wei, S.C. (2022) Improved Antitumor Immunity of Chemotherapy in OSCC Treatment by Gasdermin-E Mediated Pyroptosis. Apoptosis, 28, 348-361. https://doi.org/10.1007/s10495-022-01792-3
|
[45]
|
Yang, J., Ren, X., Zhang, L., Li, Y., Cheng, B. and Xia, J. (2018) Oridonin Inhibits Oral Cancer Growth and PI3K/Akt Signaling Pathway. Biomedicine & Pharmacotherapy, 100, 226-232. https://doi.org/10.1016/j.biopha.2018.02.011
|
[46]
|
李雯. 卡瑞利珠单抗联合DDP化疗方案对晚期非小细胞肺癌的疗效[J]. 吉林医学, 2024, 45(5): 1149-1152.
|